Return to Listing

1 result(s) for HF10

PI Name Protocol # Title
Matthew Taylor IRB00011313 A Phase II Study of Combination Treatment with HF10, a Replication-competent HSV-1 Oncolytic Virus, and Ipilimumab in Patients with Stage IIIB, Stage IIIC, or Stage IV Unresectable or Metastatic Malignant Melanoma

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080